To bypass the skin barrier, several support techniques are being studied, such as: Microneedles: Tiny needles create microchannels in the skin, allowing drugs to enter the bloodstream directly
Retatrutide: 9 mg: 34.7% 12 mg: 33.1% Placebo: 13.4% [9] Compare that to: Semaglutide: 31.5% [10] Tirzepatide: 23% at highest dose [11] In general, tirzepatide shows lower rates of common side effects
This Medication Isnt for Everyone Looking to Lose Weight, According to Doctors Given its powerful impact, retatrutide may not be the right drug for all adults with obesity, both doctors said
Weeks 9 through 12: 4 mg weekly What is happening: This is where retatrutide starts to differentiate itself from single and dual-agonist compounds
However, continuous research and vigilant monitoring are essential to optimize their safe use [55] [56], particularly as these medications are used in broader populations for longer durations
The science, as its described, is transdermal delivery